Cite
HARVARD Citation
Richards, D. et al. (n.d.). Immune cell activation by novel hexavalent CD40 agonist APG1233 compared to trimeric formats or agonistic anti-CD40 antibodies. European journal of cancer. pp. S99-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Richards, D. et al. (n.d.). Immune cell activation by novel hexavalent CD40 agonist APG1233 compared to trimeric formats or agonistic anti-CD40 antibodies. European journal of cancer. pp. S99-. [Online].